by Skin Antiseptic Products Market Size 2022 -2030, Market Share Analysis, Growth, Trends, Covid 19 Outbreak Impact Research Report Added by Precedence Research, is an In-Depth Analysis of Market Characteristics, Segmentation, Regional and Country Breakdowns, Competitive Landscape, Market Outlook, Future Scope, and Strategies for This Market.
According to Precedence Research, the global Skin Antiseptic Products market size is projected to hit USD 379.6 million by 2030 from US$ 215.17 million in 2021. Furthermore, the CAGR from 2022 to 2030 is positioned to be at a CAGR of 6.4%.
The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2022 to 2030.
Download FREE Sample of This Strategic Report with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1315
Growth Factors:
Skin antiseptic slow down the growth of microorganisms on the skin. These are generally used to reduce the risk of infection during surgery and other procedures, hand washing, and skin treatment, to decrease the risk of infections in burns, wounds, and minor cuts, in hospitals & other medical settings.
Rise in development of infection cause by hospital environment one of the major factor growing demand for skin antiseptic products. This type of infection can acquire by the patient during hospital visit. This type of infection is called as a hospital-acquired infection (HAI). Correct and frequent hand hygiene measures by all staff and patients can reduce the infection, due to this the demand for skin antiseptic products are increasing across the world.
Rising issues in endoscope reprocessing and infection control during gastrointestinal endoscopy surges the demand for skin antiseptic products. As per data published by Centers for Disease Control and Prevention (CDC), about one in 31 hospital patients has at least one healthcare-associated infection. This factors are driving the market for skin antiseptic products.
Increasing awareness of personal health and growing concern about hygiene among everyone. People are more bending towards health related products, keeping your own hand antiseptic is growing trend among everyone this is one of the major factor fueling the market for skin antiseptic product.
Report Highlights:
- Based on formulation, alcohols segment holds the highest market share due to surge in demand for alcohol base formulations and increase in usage of formulation for pre-injection and pre-operative skin preparation
- Based on application, injections segment dominating the market the increasing use of injections for extracting fluid from swollen joints for injecting medicines. And also increasing use of injections in surgeries, particularly in joint surgeries and higher application in wound care.
- Based on region, North America region is dominating the market, as increasing number of surgical procedure driving the market for skin antiseptic products in north America.
- Asia Pacific is one of the highly lucrative market owing to significantly increasing healthcare infrastructure in developing economies like India.
Future of Skin Antiseptic Product Market:
Most of the people are acquiring monotonous and unhealthy life style resulting more number of heat patients. The number of heart patient across the world is increasing significantly, majority patient are falls under surgery treatment. This factor is driving the market and it is expected to have significant growth of market in the future. Also the number of accident are rising concern around the word and majority cases needs the operative treatment, this will also increase the demand for skin antiseptic products.
COVID-19 Impact Analysis:
- Due to corona virus pandemic the use of alcohol based skin antiseptic has increased significantly.
- Also due to covid 19 pandemic the hospitals across the globe witnessed the highest crowd ever and to reduce the spread of infection the alcohol based antiseptics came up with a solution, due to which during covid it has witnessed the high demand in the market.
Key Developments in the Marketplace:
- In February 2021, Purdue Pharma L.P. has launched new Betadine Antiseptic Oral Rinse. It is an oral antiseptic pre-procedural rinse. The new products launched will contribute towards the revenue generation of the overall market.
- In February 2019, Schülke & Mayr DKSH has signed distribution agreement. DKSH market extension services providers in India. The agreement was signed to market and distribute a broad range of Schülke’s disinfectant products in China. This will helps to expand distribution process of Schulke & Mayr.
Competitive Intelligence
The Skin Antiseptic Products market report provides an understanding of the market composition and explains the role of established players and regional contributors. It is essential for the market players to make calculative moves and focus on client acquisition and retention. The detailed company profiles will provide the necessary intelligence to the reader. In order to maintain their share, the market players are focusing on strategies such as cross-border expansion, product differentiation and so on.
Some of the key players in the global Skin Antiseptic Products include:
- 3M
- Johnson & Johnson
- B Braun Melsungen
- BD
- Ecolab
- Schulke & Mayr GmbH
- Sage Products LLC.
Segments Covered in the Report
By Type
- Solutions
- Swab Sticks
- Wipes
By Formulation
- Iodine
- Alcohols
- Chlorhexidine
- Octenidine
- Others
By Application
- Surgeries
- Injection
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Skin Antiseptic Products Market, By Product
7.1. Skin Antiseptic Products Market, by Product Type, 2021-2030
7.1.1. Solutions
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Swab Sticks
7.1.2.1. Market Revenue and Forecast (2019-2030)
7.1.3. Wipes
7.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Skin Antiseptic Products Market, By Application
8.1. Skin Antiseptic Products Market, by Application, 2021-2030
8.1.1. Surgeries
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Injection
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Skin Antiseptic Products Market, By Formulation
9.1. Skin Antiseptic Products Market, by Formulation, 2021-2030
9.1.1. Iodine
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Alcohols
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Chlorhexidine
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Octenidine
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Skin Antiseptic Products Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.4.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.5.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.4.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.5.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.6.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.7.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.4.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.5.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.6.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.7.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.4.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.5.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.6.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.7.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.4.3. Market Revenue and Forecast, by Formulation (2019-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.5.3. Market Revenue and Forecast, by Formulation (2019-2030)
Chapter 11. Company Profiles
11.1. 3M
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Johnson & Johnson
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. B Braun Melsungen
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. BD
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Ecolab
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Schulke & Mayr GmbH
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Sage Products LLC.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1315
About Us
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
Contact Us:
Precedence Research
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
